đź“‹ FDA Reference
monaco rtp system
Elekta Solutions Ab
Summary: The Monaco RTP System is a radiation treatment planning system used in oncology to calculate and optimize radiation doses for cancer patients. It is primarily used by radiation oncologists and medical physicists.
FDA Clearance Information
Pathway
510K
Number
K223233 ↗
Decision Date
February 23, 2023
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
The Monaco RTP System was cleared through the FDA 510(k) pathway on February 23, 2023. It is manufactured by Elekta Solutions Ab and classified as a Class 2 medical device.
What It Is
The Monaco RTP System is a radiation treatment planning system that utilizes advanced algorithms, including the Monte Carlo method, to accurately calculate radiation doses for cancer treatment. It is designed to optimize treatment plans by simulating how radiation interacts with human tissue, ensuring precise targeting of tumors while minimizing exposure to surrounding healthy tissues.
Clinical Applications
The Monaco RTP System is commonly used in oncology departments for planning radiation therapy in cancer patients. It is particularly valuable in complex cases where precision is critical, such as in stereotactic radiosurgery or intensity-modulated radiation therapy (IMRT). The system is used by radiation oncologists and medical physicists to develop individualized treatment plans for a wide range of cancers.
Indications for Use
The FDA-cleared indications for the Monaco RTP System involve its use in planning radiation therapy for cancer patients. It is intended for calculating and optimizing radiation doses to ensure effective treatment while protecting healthy tissue.
Practical Considerations
The Monaco RTP System is compatible with various linear accelerators and integrates with existing oncology workflows. Clinicians should be trained in its use to fully leverage its advanced features. Regular software updates and maintenance are recommended to ensure optimal performance.
Related Literature
The linked study focused on using Monte Carlo modeling to simulate the Elekta Versa HD linear accelerator and perform patient dose calculations with EGSnrc/BEAMnrc. The study demonstrated the accuracy of the Monte Carlo method in dose calculation, providing a potential resource for clinics without access to commercial Monte Carlo TPSs. However, the study's applicability may be limited by the need for technical expertise in using open-source software.
Frequently Asked Questions
What is the Monaco RTP System used for?
The Monaco RTP System is used for planning and optimizing radiation therapy treatments for cancer patients.
What specialties typically use this device?
Radiation oncologists and medical physicists typically use the Monaco RTP System in oncology departments.
What are the FDA-cleared indications?
The system is indicated for planning radiation therapy to calculate and optimize doses for cancer treatment, ensuring effective targeting of tumors.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.